This company has been marked as potentially delisted and may not be actively trading. (BIOA) (BIOA) News Today Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsCompetitorsEarningsHeadlinesInsider TradesOwnershipTrendsBuy This Stock BIOA Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2025 September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 Time Period First patient treated with Leqembi® (lecanemab) in the NordicsOctober 14 at 7:55 PM | finance.yahoo.comLeqembi® Iqlik™ (lecanemab-irmb) selected by TIME as one of the best innovations of 2025October 14 at 3:12 AM | uk.finance.yahoo.comLeqembi® Iqlik™ (lecanemab-irmb) maintenance treatment launched in the U.S.October 6, 2025 | finance.yahoo.comBioArctic’s Leqembi Iqlik Launches in U.S. for Alzheimer’s MaintenanceOctober 6, 2025 | msn.comBioAge Labs files $250M mixed securities shelfOctober 2, 2025 | msn.comLeqembi® approved for IV maintenance treatment in ChinaSeptember 29, 2025 | finance.yahoo.comLeqembi® approved for the treatment of early Alzheimer's disease in AustraliaSeptember 24, 2025 | finance.yahoo.comFDA Approves BioArctic (OM:BIOA B) Lecanemab Injection For Alzheimer'sSeptember 10, 2025 | finance.yahoo.comBioArctic: Gunilla Osswald awarded Uppsala University Alumnus of the year 2025September 9, 2025 | finance.yahoo.comBioArctic's founders intend to divest minor part of their shareholdingSeptember 3, 2025 | finance.yahoo.comRolling sBLA initiated to the U.S. FDA for Leqembi® Iqlik™ (lecanemab-irmb) as a subcutaneous starting dose for the treatment of early Alzheimer's disease under Fast Track ...September 3, 2025 | finance.yahoo.comBioArctic and Eisai Advance Alzheimer’s Treatment with FDA SubmissionSeptember 3, 2025 | msn.comUS FDA approves Leqembi® IQKLIK ™ (lecanemab-irmb) subcutaneous injection for maintenance dosing for the treatment of early Alzheimer's diseaseAugust 30, 2025 | finance.yahoo.comBioArctic and Novartis sign an option, collaboration and license agreement using BrainTransporter™ for an upfront payment of USD 30 million plus additional potential ...August 26, 2025 | uk.finance.yahoo.comNovartis and BioArctic sign collaboration and license dealAugust 26, 2025 | msn.comBioArctic Partners with Novartis for Neurodegeneration TreatmentAugust 26, 2025 | msn.comLeqembi® (lecanemab) launched in the EU todayAugust 25, 2025 | finance.yahoo.comInvitation to presentation of BioArctic's second quarter report for April - June 2025 on August 28 at 9.30 a.m. CETAugust 21, 2025 | finance.yahoo.comSales of Leqembi® totaled 23.1 billion yen in the second quarter 2025August 1, 2025 | finance.yahoo.comLecanemab four-year efficacy and safety data to be presented at AAIC 2025July 22, 2025 | finance.yahoo.comBioAge Labs to Present Preclinical Data on APJ Agonism for Diabetic Obesity and Heart Failure at the American Diabetes Association (ADA) 85th Scientific SessionsJune 21, 2025 | globenewswire.comBioage Labs Inc BIOAJune 20, 2025 | morningstar.comMBioAge Labs, Inc. Common Stock (BIOA)June 18, 2025 | nasdaq.comBioAge Labs Expands Drug Discovery Platform with Data from Leading European BiobankJune 17, 2025 | globenewswire.comBioAge Labs completes IND-enabling studies for BGE-102May 30, 2025 | finance.yahoo.comBioAge Labs, Inc. (BIOA)’s BGE-102 Shows Potent Weight Loss, Plans IND Submission Mid-2025May 29, 2025 | insidermonkey.comBioAge Labs to Present at Upcoming Investor ConferencesMay 27, 2025 | globenewswire.comBioArctic AB: Bulletin from the Annual General Meeting in BioArctic AB (publ)May 23, 2025 | finanznachrichten.deBIOAGE ALERT: Bragar Eagel & Squire, P.C. is Investigating BioAge Labs, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the FirmMay 21, 2025 | globenewswire.comEisai projects Leqembi® revenue to total JPY 76.5 billion for fiscal year 2025 (April 2025 - March 2026)May 15, 2025 | finance.yahoo.comInvitation to presentation of BioArctic's first quarter report for January - March 2025 on May 21 at 9.30 a.m. CETMay 13, 2025 | finance.yahoo.comBioArctic: Exidavnemab phase 2a study expanded to include MSA patientsMay 8, 2025 | finanznachrichten.deExidavnemab phase 2a study expanded to include MSA patientsMay 8, 2025 | finance.yahoo.comWith 44% stake, BioAge Labs, Inc. (NASDAQ:BIOA) seems to have captured institutional investors' interestMay 6, 2025 | finance.yahoo.comBioAge Labs Reports First Quarter 2025 Financial Results and Provides Business UpdatesMay 6, 2025 | globenewswire.comThe European Commission refers lecanemab decision to Appeal CommitteeApril 1, 2025 | finance.yahoo.comJefferies Reaffirms Their Hold Rating on BioAge Labs, Inc. (BIOA)March 23, 2025 | markets.businessinsider.comBioAge Labs Reports Full Year 2024 Financial Results and Provides Business Updates from the Fourth Quarter of 2024March 20, 2025 | globenewswire.comFinal Deadline for the BioAge Labs, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - BIOAMarch 10, 2025 | prnewswire.comBIOA Deadline Today: BIOA Investors Have Opportunity to Lead BioAge Labs, Inc. Securities LawsuitMarch 10, 2025 | prnewswire.comBIOA DEADLINE TODAY: ROSEN, LEADING INVESTOR COUNSEL, Encourages BioAge Labs, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important March 10 Deadline in Securities Class Action – BIOAMarch 10, 2025 | globenewswire.comLost Money on BioAge Labs, Inc. (BIOA)? Join Class Action Suit Seeking Recovery – Contact Levi & KorsinskyMarch 10, 2025 | globenewswire.comBIOA FINAL DEADLINE: BioAge Labs Investors are Encouraged to Contact BFA Law before the Expiration of Today's Class Action DeadlineMarch 10, 2025 | globenewswire.comBioAge Labs, Inc. Class Action: The Gross Law Firm Reminds BioAge Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of March 10, 2025 - BIOAMarch 10, 2025 | prnewswire.comBIOA Final Opportunity to Lead BioAge Labs, Inc. Securities Fraud Lawsuit with the Schall Law FirmMarch 10, 2025 | prnewswire.comBIOA DEADLINE TOMORROW: BioAge Labs Investors are Notified to Contact BFA Law before Tomorrow's March 10 Class Action DeadlineMarch 9, 2025 | markets.businessinsider.comBIOA Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds BioAge Labs, Inc. (BIOA) Investors of Filing Deadline in Class Action LawsuitMarch 8, 2025 | theglobeandmail.comBIOA LEGAL NEWS: A Class Action was filed on behalf of BioAge Labs Investors - Contact BFA Law if You Suffered LossesMarch 8, 2025 | globenewswire.comDeadline Soon: BioAge Labs, Inc. (BIOA) Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz About Securities Fraud LawsuitMarch 7, 2025 | tmcnet.comBIOA LEGAL NOTICE: BioAge Labs Investors are Notified of Upcoming Class Action Deadline and are Urged to Contact BFA LawMarch 7, 2025 | markets.businessinsider.com Get (BIOA) News Delivered to You Automatically Sign up to receive the latest news and ratings for BIOA and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BIOA Media Mentions By Week BIOA Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BIOA News Sentiment▼0.000.72▲Average Medical News Sentiment BIOA News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BIOA Articles This Week▼25▲BIOA Articles Average Week Get the Latest News and Ratings for BIOA and Related Stocks Enter your email address to receive the latest news and analysts' ratings for (BIOA) and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Silverback Therapeutics News Aerovate Therapeutics News Neoleukin Therapeutics News Virios Therapeutics News Spruce Biosciences News Aadi Bioscience News Actinium Pharmaceuticals News Eagle Pharmaceuticals News PyroGenesis Canada News NanoViricides News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BIOA) was last updated on 10/16/2025 by MarketBeat.com Staff From Our PartnersURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredGenerate up to $5,000/month with 10X less money?The secret to retiring without a million-dollar nest egg. I'm talking about generating enough monthly inco...Investors Alley | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredGold to $27,533?This week, U.S. gold reserves hit an unprecedented $1 TRILLION in value... And it's sparking urgent chatter...Stansberry Research | SponsoredShots officially fired…Elon Musk just declared war on the wireless giants with a $17 billion spectrum deal that gives SpaceX the righ...Brownstone Research | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding (BIOA) Please log in to your account or sign up in order to add this asset to your watchlist. Share (BIOA) With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
